XiFin, Inc.

🏆 For the 6th consecutive year, Black Book Market Research LLC reports that XiFin, Inc. was named the #1 provider of outsourced RCM solutions and services across hospitals, outpatient and diagnostic laboratories, and radiology and diagnostic imaging facilities. Based on feedback from 3,125 healthcare and medical professionals, XiFin received “overwhelming satisfaction” in all 18 key performance metrics and was the #1 ranked provider in 14 of the 18 categories. This extensive survey included insights from 1,093 hospital professionals, 389 outpatient and diagnostic laboratory facilities, 441 physicians, and 809 radiology centers and diagnostic imaging facilities, all contributing to the annual poll measuring customer and user satisfaction. Want to know how your RCM provider stacks up? Download the full 2024 Black Book Report free at https://hubs.li/Q02Y8rzZ0 #XiFin #RevenueCycleManagement #RCM #HealthcareInnovation #ClientExperience #BlackBookSurvey #HealthTech

Boost Reimbursement Through Better Patient Engagement In Part 2 of our blog series, we explore how enhancing the patient experience—from clear communication to transparency—can reduce payment delays and streamline billing in DME and remote monitoring. Discover actionable insights to improve outcomes. 👉 Read the blog now: https://hubs.li/Q02__2Ck0 Missed Part 1? Find it here: https://hubs.li/Q02__44t0

Maximizing DME Reimbursement for Complex Billing Scenarios Offering DME in your pharmacy can unlock growth but comes with billing challenges. Part 1 of our blog series explores: ✅ Reimbursement pathways & hurdles ✅ Common pitfalls like coding misalignment & prior authorizations ✅ How automation & BI drive success 👉 Read now: https://hubs.li/Q02_spN20 #DMEBilling #DurableMedicalEquipment

Fostering Resilience in Diagnostics: Insights from the CCLA Conference Diagnostics are reshaping healthcare outcomes, but economic and regulatory pressures create hurdles. Explore highlights from XiFin CEO Lâle White’s talk at the 2024 CCLA Conference, discussing: ✅ Economic and demographic pressures ✅ Medicare Advantage’s impact on labs ✅ Strategies to foster innovation and advocacy 📖 Read the blog: https://hubs.li/Q02_s9Q60 #Diagnostics #HealthcareInnovation #CCLA2024

📢XiFin Recognized for Innovation and Excellence in RCM We’re thrilled to announce that XiFin is wrapping up the year on a high note, earning prestigious recognition from Modern Healthcare and receiving editorial accolades for our award-winning revenue cycle management (RCM) solution. These awards are a testament to our team's unwavering commitment to innovation, excellence, and empowering healthcare organizations to achieve better financial and operational outcomes. A huge thank you to our clients, partners, and team members who make this success possible. Together, we’re driving transformative results in healthcare. 📢 Read the full press release here to learn more: https://hubs.li/Q02_FxtS0 #HealthcareInnovation #RCMExcellence #XiFin #ModernHealthcare #HealthcareLeadership #RevenueCycleManagement

MRD testing is advancing personalized oncology but poses billing challenges. Learn how to navigate coding complexity, streamline prior authorizations, and optimize reimbursement while improving patient care. Read insights from experts Heather Agostinelli and Shauna Hay in our blog: 👉 https://hubs.li/Q02_snXP0

Navigate Pathology Denials with Confidence Denials in pathology are improving but remain a financial risk. Learn key strategies to optimize RCM, automate appeals, and reduce administrative costs in our latest blog. ✅ Top denial trends & insights ✅ Automation strategies for appeals ✅ Payor-specific tips to reduce denials 📖 Read now: https://hubs.li/Q02_wB6w0 #Pathology #RCMSuccess #HealthcareInnovation

Join us tomorrow for The Dark Intelligence Group webinar, 2024 Payor Denial Impact Report – Data-Driven Strategies for Denial Management and Appeals Success 💡 What you’ll learn: ✔️ Key denial reasons by segment ✔️ Top appeal strategies and success trends ✔️ Optimizing AI and automation for RCM ✔️ Must-watch 2024 payor policies 📅 When: Wednesday, Dec 11, 2024 10:00 AM PT | 1:00 PM ET 📲 Register now: https://hubs.li/Q02_7F8T0 #DenialManagement #HealthcareFinance #AppealsSuccess #RCMSolutions #XiFinWebinar

Don't miss the upcoming The Dark Intelligence Group webinar: 2024 Payor Denial Impact Report – Data-Driven Strategies for Denial Management and Appeals Success. 💡 What’s in it for you? Hear from XiFin industry experts Diana Richard and Stephanie Denham as they break down critical insights, including: - Key denial reasons by segment and payor group - Top appeal success trends and strategies - How to optimize productivity with AI and automation - Must-watch payor policies for 2024 This is your opportunity to stay ahead of the curve and strengthen your denial management strategies with actionable, data-driven insights. 📅 When: Wednesday, December 11, 2024 10:00 AM PT | 1:00 PM ET 📲 Register now: https://hubs.li/Q02Zc96t0 #DenialManagement #HealthcareFinance #AppealsSuccess #XiFinWebinar #DARKDaily

Struggling with denials for molecular diagnostics claims? In the second blog post of a three-part series, we explore molecular diagnostics denial trends and how a strategic, three-phase appeal approach can turn challenges into opportunities. Learn how to streamline appeals and maximize reimbursement success in our latest blog: https://hubs.li/Q02YRjwg0 #MolecularDiagnostics #RevenueCycleManagement #HealthcareReimbursement #ClaimDenials #AppealStrategies #MedicalBilling #HealthcareInnovation #RCMStrategies